EA201791901A1 - Антагонисты рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на теле - Google Patents
Антагонисты рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на телеInfo
- Publication number
- EA201791901A1 EA201791901A1 EA201791901A EA201791901A EA201791901A1 EA 201791901 A1 EA201791901 A1 EA 201791901A1 EA 201791901 A EA201791901 A EA 201791901A EA 201791901 A EA201791901 A EA 201791901A EA 201791901 A1 EA201791901 A1 EA 201791901A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- neurokinin
- receptor
- antagonists
- therapeutic
- fats
- Prior art date
Links
- 102000002003 Neurokinin-3 Receptors Human genes 0.000 title abstract 2
- 108010040716 Neurokinin-3 Receptors Proteins 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title 1
- 239000003925 fat Substances 0.000 title 1
- 239000002740 neurokinin 3 receptor antagonist Substances 0.000 abstract 2
- 230000001575 pathological effect Effects 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
Настоящее изобретение относится к применению антагонистов рецептора нейрокинина-3 (NK3R) для терапевтического лечения патологических излишних жировых отложений на теле и/или предотвращения прибавления жировых отложений на теле у пациентов. Также настоящее изобретение относится к косметологическому способу для стимулирования потери избытка жировых отложений на теле, согласно которому вводят антагонист рецептора NK-3.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15159296 | 2015-03-16 | ||
| EP15193513 | 2015-11-06 | ||
| PCT/EP2016/055735 WO2016146712A1 (en) | 2015-03-16 | 2016-03-16 | Nk-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201791901A1 true EA201791901A1 (ru) | 2018-04-30 |
| EA036709B1 EA036709B1 (ru) | 2020-12-10 |
Family
ID=55538244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201791901A EA036709B1 (ru) | 2015-03-16 | 2016-03-16 | Применение антагонистов рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на теле |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US10624890B2 (ru) |
| EP (1) | EP3271015B8 (ru) |
| JP (1) | JP6762312B2 (ru) |
| KR (2) | KR20240033207A (ru) |
| CN (1) | CN107405347B (ru) |
| AU (1) | AU2016232191B2 (ru) |
| BR (1) | BR112017019829A2 (ru) |
| CA (1) | CA2977444A1 (ru) |
| DK (1) | DK3271015T3 (ru) |
| EA (1) | EA036709B1 (ru) |
| ES (1) | ES2965675T3 (ru) |
| FI (1) | FI3271015T3 (ru) |
| HR (1) | HRP20231661T1 (ru) |
| HU (1) | HUE064813T2 (ru) |
| IL (1) | IL254386B (ru) |
| LT (1) | LT3271015T (ru) |
| MX (1) | MX2017011937A (ru) |
| NZ (2) | NZ734635A (ru) |
| PL (1) | PL3271015T3 (ru) |
| RS (1) | RS65039B1 (ru) |
| SG (1) | SG11201707521QA (ru) |
| SI (1) | SI3271015T1 (ru) |
| WO (1) | WO2016146712A1 (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113194948A (zh) * | 2018-11-15 | 2021-07-30 | 国立大学法人九州大学 | Il-31介导性疾病的预防或治疗剂及医药组合物 |
| CN112272670B (zh) * | 2019-04-16 | 2023-12-12 | 上海翰森生物医药科技有限公司 | 含二并环类衍生物抑制剂、其制备方法和应用 |
| CN117177974A (zh) * | 2021-04-21 | 2023-12-05 | 长春金赛药业有限责任公司 | 含咪唑稠环类衍生物、其制备方法及其在医药上的应用 |
| CN114288292B (zh) * | 2021-12-10 | 2023-06-13 | 中南大学湘雅医院 | 芳香族化合物作为神经丛素蛋白-b2的激活剂以及在制备治疗骨质疏松症药物中的应用 |
| WO2023147134A2 (en) * | 2022-01-31 | 2023-08-03 | Acer Therapeutics, Inc. | Methods for treating patients having low estrogen with nk3 antagonists |
| WO2024083150A1 (zh) * | 2022-10-19 | 2024-04-25 | 长春金赛药业有限责任公司 | 一种nk3r拮抗剂的晶型及其制备方法和应用 |
| WO2024083160A1 (zh) * | 2022-10-21 | 2024-04-25 | 长春金赛药业有限责任公司 | 吲哚啉螺环类化合物的晶型、无定形物及二者的制备方法和应用 |
| WO2024083164A1 (zh) * | 2022-10-21 | 2024-04-25 | 长春金赛药业有限责任公司 | 吲哚啉螺环类化合物的溶剂化物及其晶型、制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008131779A1 (en) | 2007-04-26 | 2008-11-06 | H. Lundbeck A/S | Isoquinolinone derivatives as nk3 antagonists |
| US10065960B2 (en) | 2010-04-02 | 2018-09-04 | Ogeda Sa | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders |
| EP2552920B1 (en) | 2010-04-02 | 2017-03-15 | Ogeda Sa | Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders |
| DK2763992T3 (en) | 2011-10-03 | 2016-04-25 | Euroscreen Sa | NOVEL CHIRAL N-acyl-5,6,7, (8-substituted) -tetrahydro [1,2,4] triazolo [4,3-a] pyrazines as selective NK-3 receptor antagonists, PHARMACEUTICAL COMPOSITION AND METHODS FOR THE use in the NK-3 receptor mediated diseases |
| WO2014154896A1 (en) | 2013-03-29 | 2014-10-02 | Euroscreen Sa | NOVEL N-ACYL-(3-SUBSTITUTED)-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR-MEDIATED DISORDERS |
| SG11201508005XA (en) | 2013-03-29 | 2015-10-29 | Euroscreen Sa | NOVEL N-ACYL-(3-SUBSTITUTED)-(8-SUBSTITUTED)-5,6-DIHYDRO- [1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR-MEDIATED DISORDERS |
| US9840508B2 (en) | 2013-03-29 | 2017-12-12 | Oged Sa | N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a] pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders |
| WO2016046398A1 (en) | 2014-09-25 | 2016-03-31 | Euroscreen Sa | Novel chiral synthesis of n-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines |
-
2016
- 2016-03-16 SG SG11201707521QA patent/SG11201707521QA/en unknown
- 2016-03-16 EA EA201791901A patent/EA036709B1/ru not_active IP Right Cessation
- 2016-03-16 PL PL16710199.7T patent/PL3271015T3/pl unknown
- 2016-03-16 AU AU2016232191A patent/AU2016232191B2/en active Active
- 2016-03-16 HR HRP20231661TT patent/HRP20231661T1/hr unknown
- 2016-03-16 BR BR112017019829A patent/BR112017019829A2/pt not_active Application Discontinuation
- 2016-03-16 ES ES16710199T patent/ES2965675T3/es active Active
- 2016-03-16 MX MX2017011937A patent/MX2017011937A/es unknown
- 2016-03-16 KR KR1020237033062A patent/KR20240033207A/ko unknown
- 2016-03-16 FI FIEP16710199.7T patent/FI3271015T3/fi active
- 2016-03-16 NZ NZ734635A patent/NZ734635A/en unknown
- 2016-03-16 LT LTEPPCT/EP2016/055735T patent/LT3271015T/lt unknown
- 2016-03-16 SI SI201631784T patent/SI3271015T1/sl unknown
- 2016-03-16 US US15/557,832 patent/US10624890B2/en active Active
- 2016-03-16 JP JP2017546590A patent/JP6762312B2/ja active Active
- 2016-03-16 WO PCT/EP2016/055735 patent/WO2016146712A1/en active Application Filing
- 2016-03-16 CA CA2977444A patent/CA2977444A1/en active Pending
- 2016-03-16 DK DK16710199.7T patent/DK3271015T3/da active
- 2016-03-16 EP EP16710199.7A patent/EP3271015B8/en active Active
- 2016-03-16 CN CN201680015846.XA patent/CN107405347B/zh active Active
- 2016-03-16 HU HUE16710199A patent/HUE064813T2/hu unknown
- 2016-03-16 RS RS20231223A patent/RS65039B1/sr unknown
- 2016-03-16 NZ NZ773981A patent/NZ773981A/en unknown
- 2016-03-16 KR KR1020177026643A patent/KR20170124566A/ko not_active Application Discontinuation
-
2017
- 2017-09-07 IL IL254386A patent/IL254386B/en active IP Right Grant
-
2020
- 2020-02-20 US US16/796,422 patent/US11478472B2/en active Active
-
2022
- 2022-09-13 US US17/943,711 patent/US20230039022A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201791901A1 (ru) | Антагонисты рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на теле | |
| EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
| EA201792304A1 (ru) | Комбинированная терапия для лечения рака | |
| IL276383B1 (en) | Treatment of ophthalmological diseases | |
| EA201690212A1 (ru) | Способы лечения или профилактики офтальмологических патологических состояний | |
| EA201691567A1 (ru) | Способы лечения легких травм головного мозга | |
| EA201892265A1 (ru) | Способы лечения офтальмологических заболеваний | |
| EA201792610A1 (ru) | Способ лечения неврологического заболевания | |
| EA201792571A1 (ru) | Терапевтическое применение l-4-хлорокинуренина | |
| EA201892297A1 (ru) | Способы лечения холестатических и фибротических заболеваний | |
| ZA202002075B (en) | Compounds, compositions and methods for treatment of eye disorders and skin diseases | |
| EA201790893A1 (ru) | Способы лечения офтальмологических расстройств | |
| EA202090266A1 (ru) | Ингибиторы mpo для применения в медицине | |
| EA201792445A1 (ru) | Новые амидогетероарилароилгидразидэтины | |
| SG11202007082PA (en) | Composition used for therapeutic treatment of skin disease | |
| EA201800565A1 (ru) | Композиция для лечения заболеваний уха, содержащая (+)-азасетрон | |
| EA202092184A2 (ru) | Антагонисты рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на теле | |
| EA201790537A1 (ru) | Дипептидилкетоамидные соединения и их применение для лечения и/или предотвращения накопления жира | |
| MA51658A (fr) | Association comprenant un antagoniste de nk1 et méthode de traitement de synucléinopathies | |
| MA40574A (fr) | Traitement de maladies fibrotiques | |
| PT3271015T (pt) | Antagonistas do recetor nk-3 para tratamento terapêutico ou cosmético do excesso de gordura corporal | |
| GB201811912D0 (en) | Treatment of disease | |
| GB201811911D0 (en) | Treatment of disease | |
| GB201810974D0 (en) | Treatment of disease | |
| IL263837A (en) | Treatment of ocular disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |